Legend Biotech (LEGN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Legend Biotech is undergoing a significant financial restructuring as Genscript Biotech has decided to deconsolidate the company’s financial statements. This move follows Genscript’s loss of control over voting power at Legend Biotech’s 2024 Annual General Meeting. Investors in the biotech sector may find this development noteworthy as it could impact the company’s financial reporting and market perception.
For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.
